Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GLP-1 Drug Coverage Growing For Obesity In Medicaid, But Only For Diabetes In Medicare

10 Apr 2025

• By Cathy Kelly

Obesity drugs will not receive the required access in government sponsored insurance ... yet. (Shutterstock)

Related Content

Medicare, Medicaid Coverage Of Obesity Drugs Would Add $40bn In Government Spending

26 Nov 2024

Health Insurers May Sue if CMS Finalizes Obesity Drug Coverage Expansion

11 Mar 2025

Dr. Oz Takes Over CMS Amid Major Transformation Of Medicare Part D

04 Apr 2025

Medicaid Cuts Could Prompt States To Tighten Drug Cost Controls, Former CMS Official Says

11 Mar 2025

Related Companies

Novo Nordisk A/S

Eli Lilly and Company

More from Medicare

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.